Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Short Interest Update

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) was the recipient of a significant decline in short interest in February. As of February 28th, there was short interest totalling 17,050,000 shares, a decline of 16.7% from the February 13th total of 20,470,000 shares. Based on an average daily trading volume, of 2,130,000 shares, the short-interest ratio is presently 8.0 days. Approximately 7.3% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

A number of brokerages have commented on SBRA. Mizuho restated a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target on the stock in a research report on Tuesday, January 7th. Truist Financial upped their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Tuesday. Finally, Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Sabra Health Care REIT currently has a consensus rating of “Moderate Buy” and an average target price of $19.33.

Institutional Trading of Sabra Health Care REIT

A number of hedge funds have recently made changes to their positions in SBRA. Principal Financial Group Inc. grew its stake in Sabra Health Care REIT by 2.5% in the fourth quarter. Principal Financial Group Inc. now owns 22,109,683 shares of the real estate investment trust’s stock valued at $382,940,000 after purchasing an additional 536,247 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Sabra Health Care REIT by 4.3% in the 4th quarter. JPMorgan Chase & Co. now owns 10,312,991 shares of the real estate investment trust’s stock worth $178,621,000 after purchasing an additional 426,074 shares during the last quarter. Geode Capital Management LLC boosted its position in Sabra Health Care REIT by 1.4% during the fourth quarter. Geode Capital Management LLC now owns 6,381,525 shares of the real estate investment trust’s stock worth $110,550,000 after purchasing an additional 86,727 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Sabra Health Care REIT by 8.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 4,701,881 shares of the real estate investment trust’s stock worth $87,502,000 after purchasing an additional 365,855 shares during the period. Finally, Northern Trust Corp grew its holdings in Sabra Health Care REIT by 27.7% during the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust’s stock valued at $72,214,000 after purchasing an additional 905,466 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Health Care REIT Price Performance

Shares of NASDAQ:SBRA traded up $0.19 during trading hours on Tuesday, hitting $17.81. 1,128,891 shares of the company’s stock traded hands, compared to its average volume of 1,951,216. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. The company’s fifty day simple moving average is $16.74 and its two-hundred day simple moving average is $17.67. Sabra Health Care REIT has a 52 week low of $13.31 and a 52 week high of $20.03. The company has a market cap of $4.24 billion, a price-to-earnings ratio of 33.61, a price-to-earnings-growth ratio of 1.97 and a beta of 1.27.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.36. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. As a group, equities analysts anticipate that Sabra Health Care REIT will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 6.74%. Sabra Health Care REIT’s payout ratio is presently 226.42%.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.